Anuh Pharma share price target 2027 is Rs 81.00 (+1%), 2028 is Rs 89.00 (+11%), and 2030 is Rs 108 (+35%). Pharma and Healthcare stock long term analyst forecas

Anmol India share price target 2027 is Rs 12.00 (+14%), 2028 is Rs 13.00 (+21%), and 2030 is Rs 14.00 (+33%). Diversified stock long term analyst forecast.

Anlon Healthcare share price target 2027 is Rs 18.00 (+20%), 2028 is Rs 23.00 (+52%), and 2030 is Rs 36.00 (+137%). Pharma and Healthcare stock long term analys

AksharChem India share price target 2027 is Rs 305 (+35%), 2028 is Rs 330 (+46%), and 2030 is Rs 380 (+68%). Diversified stock long term analyst forecast.

Aeroflex Neu share price target 2027 is Rs 93.00 (+6%), 2028 is Rs 104 (+19%), and 2030 is Rs 131 (+50%). Diversified stock long term analyst forecast.

Info Edge share pros and cons: Naukri jobs platform monopoly and digital classifieds leader analysed for 2026. Zomato investment gains, IT hiring sensitivity, 99acres growth, and high PE covered.

PolicyBazaar share pros and cons: India’s insurance distribution platform leader analysed for 2026. Platform scale, insurance penetration opportunity, profitability path, IRDA risks, and high PE covered.

ABB India share pros and cons: Swiss automation giant’s India business analysed for 2026. Electrification leadership, data centre power infrastructure, EV charging growth, high PE, and parent royalty risks covered.

Bharat Electronics share pros and cons: India’s defence electronics PSU analysed for 2026. Monopoly positioning, strong order book, Make-in-India tailwind, high PE, and PSU governance risks covered.

Dixon Technologies share pros and cons: India’s EMS leader at 41x PE analysed for 2026. Samsung partnership, PLI scheme benefits, thin margin risks, and China Plus One tailwind covered.